J C H van der Hilst
Overview
Explore the profile of J C H van der Hilst including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
241
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Baecke C, Gyssens I, Decoutere L, van der Hilst J, Messiaen P
Neth J Med
. 2017 Jul;
75(6):235-240.
PMID: 28741582
Background: Antiretroviral agents pose a high risk for drug-drug interactions (DDIs), mainly but not limited to being a substrate, inducer or inhibitor of P450 cytochrome enzymes. In part metabolised by...
2.
Messiaen P, Peeters K, van Esbroeck M, Bijnens E, Wouters K, Gyssens I, et al.
Neth J Med
. 2016 Mar;
74(2):96-7.
PMID: 26951358
No abstract available.
3.
van der Hilst J
ScientificWorldJournal
. 2011 Mar;
11:641-50.
PMID: 21403980
The amyloidoses are a group of life-threatening diseases in which fibrils made of misfolded proteins are deposited in organs and tissues. The fibrils are stable, insoluble aggregates of precursor proteins...
4.
van der Hilst J, Kluve-Beckerman B, van der Meer J, Simon A
Eur J Clin Invest
. 2009 Sep;
39(5):412-6.
PMID: 19740371
Background: The extracellular, fibrillar deposits of reactive (secondary) amyloidosis are composed of amyloid A (AA) protein, a proteolytically derived fragment of the acute phase protein serum amyloid A (SAA). While...
5.
van der Hilst J, Yamada T, op den Camp H, van der Meer J, Drenth J, Simon A
Rheumatology (Oxford)
. 2008 Sep;
47(11):1651-4.
PMID: 18815155
Objective: Genetic polymorphisms in serum amyloid A (SAA) have been shown to substantially influence the risk of developing type AA amyloidosis. Recently, a role for MMP-1 has been suggested in...
6.
van der Hilst J, Kluve-Beckerman B, Bodar E, van der Meer J, Drenth J, Simon A
J Leukoc Biol
. 2008 Feb;
83(5):1295-9.
PMID: 18285405
Amyloid A (AA) amyloidosis is a severe complication of many chronic inflammatory disorders, including the hereditary periodic fever syndromes. However, in one of these periodic fever syndromes, the hyper IgD...
7.
van der Hilst J, van der Meer J, Drenth J, Simon A
Br J Dermatol
. 2007 Feb;
156(4):748-9.
PMID: 17263824
No abstract available.
8.
van der Hilst J, Simon A, Drenth J
Clin Exp Med
. 2005 Nov;
5(3):87-98.
PMID: 16284730
Hereditary periodic fever syndromes (HPF) are a group of diseases characterised by recurrences of fever and inflammation separated by symptom-free intervals. Familial Mediterranean fever (FMF) is the most frequent entity...
9.
de Koning H, Bodar E, Simon A, van der Hilst J, Netea M, van der Meer J
Ann Rheum Dis
. 2005 Aug;
65(4):542-4.
PMID: 16096327
Background: Schnitzler's syndrome is an inflammatory disorder characterised by chronic urticarial rash and monoclonal gammopathy, accompanied by periodic fever, arthralgia or arthritis, and bone pain. The cause and treatment are...
10.
Bodar E, van der Hilst J, Drenth J, van der Meer J, Simon A
Neth J Med
. 2005 Aug;
63(7):260-4.
PMID: 16093577
Background: Hyper-IgD and periodic fever syndrome (HIDS) is an hereditary autoinflammatory syndrome, characterised by recurrent inflammatory attacks. Treatment of HIDS is difficult, although simvastatin is beneficial and etanercept might be...